Archean ChemicalQ4 FY24

Archean Chemical Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹439.5P/E: 54.4Market Cap: ₹5.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • FY'25 volume growth expected at least 30% over FY'24.
  • Bromine volume target for FY'25 is around 28,000 to 29,000 tons, with stronger sales in the second half.
  • Revenue from Phase 1 bromine derivatives expected between INR 200 to 250 crores in FY'25, ramping up post first quarter.
  • Phase 1 includes 15,000 to 20,000 tons production capacity for derivatives in first year.
  • SOP (Sulphate of Potash) expected to contribute meaningfully from H2 FY'25, with second-grade SOP production started.
  • Industrial Salt volumes expected to grow over FY'24 levels.
  • Phase 2 bromine derivatives (flame retardants) commercialization anticipated by 1H FY'25 – timing is under evaluation.
  • Oren Hydrocarbon plant restart expected to generate INR 100 to 250 crores revenue in FY'25 with partial operation (2-3 quarters).
  • Bromine consumption in derivatives at peak Phase 1 utilization expected around 10,000–15,000 tons.

See what Archean Chemical management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • The management mentioned that the money for Phase 2 capex, especially for the FR-related project, has already been raised and is available with the company.
  • They have taken a pause on committing further capex for Phase 2 to time it correctly according to market conditions.
  • There is no indication of immediate new fundraising through debt or equity in the current call.
  • The company is focusing on utilizing the capex already spent on Phase 1 and expanding the product portfolio within that.
  • Further capital expenditures will be assessed based on market developments and product pricing, with no explicit mention of new fundraising plans for the near term.

See what Archean Chemical management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Phase 1 greenfield expansion of bromine derivative plant at Jhagadia (subsidiary Acume Chemicals) commissioned in March 2024; focuses on bromine performance derivatives and clear brine fluids.
  • Additional Phase 1 expansion with new product portfolio expected by end of H1 FY '25; includes industrial bromine derivatives for oil & gas drilling, agrochemical intermediates, and petrochemical chain products.
  • Total Phase 1 capex spent approx. INR 130-140 crores, with an additional INR 30-40 crores to complete Phase 1 pipeline.
  • Phase 2 (focused on flame retardants - FR products) planned for second half of FY '25, but currently on hold to optimize use of Phase 1 capex and evaluate market pricing for FR products.
  • Work started to refurbish and restart Oren Hydrocarbon plant (acquired via wholly owned subsidiary Idealis Chemicals); pending NCLT approvals with anticipated revenue between INR 100-250 crores in FY '25.
  • No specific timeline for further capex on flow battery R&D or power electronics subsidiary (Sicsem Pvt Ltd); updates to follow as projects mature.

Track Archean Chemical — get its next earnings analysis in your feed

How does Archean Chemical rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisArchean Chemical
Rev 2Mar 3

How does Archean Chemical rank in Chemicals & Petrochemicals?

Compare Archean Chemical against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →